FDA Inspection 733258 — Ameriderm Laboratories, Ltd.

Ameriderm Laboratories, Ltd. — FEI 3001452902

The FDA completed an inspection of Ameriderm Laboratories, Ltd. on Jun 29, 2011 in Paterson, NJ. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). 12 citations were issued during this inspection. Product area: Drugs.

Inspection details

Classification
Voluntary Action Indicated (VAI)
End Date
Jun 29, 2011
Fiscal Year
2011
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Paterson, NJ (United States)

Citations

IDCFRDescription
103321 CFR 211.22(a)Authority lacking to review records, investigate errors
110521 CFR 211.22(d)Procedures not in writing, fully followed
136121 CFR 211.100(a)Absence of Written Procedures
180221 CFR 211.84(b)Representative Samples
188321 CFR 211.165(a)Testing and release for distribution
191421 CFR 211.166(a)Lack of written stability program
197521 CFR 211.182Written records kept in individual logs
358521 CFR 211.110(a)Control procedures to monitor and validate performance
359221 CFR 211.110(c)In-process materials characteristics testing
430321 CFR 211.67(b)Written procedures fail to include
438221 CFR 211.198(b)(2)Written record of complaint to include findings, follow-up
440121 CFR 211.186(b)(9)Complete instructions, procedures, specifications et. al.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.